López-Cortés Andrés, Guerrero Santiago, Redal María Ana, Alvarado Angel Tito, Quiñones Luis Abel
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito 170527, Ecuador.
Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Universitat Pompeu Fabra (UPF), Barcelona 08003, Spain.
Int J Mol Sci. 2017 May 23;18(6):639. doi: 10.3390/ijms18060639.
Over the past decades, several studies have shown that tumor-related somatic and germline alterations predicts tumor prognosis, drug response and toxicity. Latin American populations present a vast geno-phenotypic diversity due to the great interethnic and interracial mixing. This genetic flow leads to the appearance of complex characteristics that allow individuals to adapt to endemic environments, such as high altitude or extreme tropical weather. These genetic changes, most of them subtle and unexplored, could establish a mutational profile to develop new pharmacogenomic therapies specific for Latin American populations. In this review, we present the current status of research on somatic and germline alterations in Latin America compared to those found in Caucasian and Asian populations.
在过去几十年里,多项研究表明,与肿瘤相关的体细胞和种系改变可预测肿瘤预后、药物反应及毒性。由于拉丁美洲人群存在大量族裔间和种族间的混合,该地区人群呈现出广泛的基因表型多样性。这种基因流动导致出现复杂特征,使个体能够适应地方病环境,如高海拔或极端热带气候。这些基因变化大多细微且未被探索,可能会形成一种突变谱,以开发针对拉丁美洲人群的新型药物基因组学疗法。在这篇综述中,我们展示了拉丁美洲人群体细胞和种系改变的研究现状,并与高加索人群和亚洲人群的研究结果进行比较。